Company Profile · Healthcare

Koninklijke Philips NV

PHIA · Amsterdam
Country
Netherlands
Employees
63,670
Buffett Score
38/100
Weak
Market cap€20.79B
Revenue (TTM)€17.66B
EBITDA€2.42B
Profit margin6.31%
ROE10.15%
P/E (TTM)18.66
Forward P/E12.64
PEG0.75
EPS€1.14
Dividend yield4.01%
52-week range€20.64 – €26.67

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

No reports on this stock in your language yet.